4DMedical Limited (ASX:4DX) Annual Report 2020



The latest annual report of 4DMedical Limited (4DX) was published on 30 Jun 2020. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - 4DX Annual Results

Amounts in AUD

Total Revenue
1.23M
Gross Profit
111.39k
EBIT
-15.96M
Net Tangible Assets
-12.32M
Net Income
-21.98M
Capital Expenditures
-325.3k

4DX Income Statement 2020 Annual Report

As per the latest Income Statement of 4DX, the Net revenue increased by $537500 (77%) compared to the previous period. The operating income in 2020 decreased by $-8.94M (-127%). The net income as per the annual report was -21.98M which decreased by $-15.48M (-239%) compared to previous year.

Income Statement Report (2020/2019)

20202019
Total Revenue1.23M695k
Gross Profit111.39k63.61k
Operating Income-15.96M-7.02M
Income Before Tax-21.97M-6.49M
Net Income-21.98M-6.49M

Balance Sheet - 4DX 2020 Annual Report

Read further: 4DX Balance Sheet Detailed Analysis

The latest balance sheet from annual result of 4DMedical Limited showed the company increased the cash on balance sheet by $5.34M (173%). The Net tangible assets of 4DX on the balance sheet were at -12.32M which is $-16.51M (-395%) less than previous annual report. The total stockholder equity also decreased by $-16.37M (-359%) compared to previous reporting period.

Balance Sheet Statement Report (2020/2019)

20202019
Cash8.43M3.09M
Total Assets15.82M 9.02M
Long Term Debt-1.5M
Total Liabilities27.63M 4.47M
Total Shareholder Equity-11.81M4.56M
Net Tangible Assets-12.32M4.18M

Cash Flow Statement - 4DX 2020 Annual Report

The 2020 annual cash flow statement of 4DMedical Limited showed that the net income decreased by $-15.48M (-239%) compared to previous reporting period. Also the capital expenditure of 4DX increased by $199276 (38%).

As of 2020, the total cash from investing activities was -786.45k and total cash from financing activities was 13.78M.

Cash Flow Statement Report (2020/2019)

20202019
Net Income-21.98M-6.49M
Capital Expenditures-325.3k-524.57k
Dividends Paid--
Total Cash From From Investing Activities-786.45k-1.03M
Total Cash From From Financing Activities13.78M8.23M

4DMedical Limited Annual Report History

Income Statement

Income Statement history of 4DMedical Limited (ASX:4DX)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Total Revenue1.23M695k1.38M681.86k
Cost Of Revenue1.12M631.39k1.03M676
Gross Profit111.39k63.61k351.13k681.18k
Research Development----
Selling General Administrative7.66M3.69M2.61M2.81M
Non Recurring----
Other Operating Expenses7.83M3.29M2.16M1.75M
Total Operating Expenses17.19M7.71M5.96M4.68M
Operating Income-15.96M-7.02M-4.58M-4M
Total Other Income Expense Net-6.01M530.78k643.79k25.03k
Ebit-15.96M-7.02M-4.58M-4M
Interest Expense-8.02M-254.52k-254.52k-254.52k
Income Before Tax-21.97M-6.49M-3.94M-3.97M
Income Tax Expense1.76k4.14k--
Minority Interest----
Net Income From Continuing Ops-21.98M-6.49M-3.94M-3.97M
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income-21.98M-6.49M-3.94M-3.97M
Net Income Applicable To Common Shares-21.98M-6.49M-3.94M-3.97M

Balance Sheet Statement

Balance Sheet Statement history of 4DMedical Limited (ASX:4DX)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Cash8.43M3.09M1.66M1.15M
Net Receivables1.75M1.6M1.33M1.3M
Inventory16.05k628.76k22.8k700.69k
Other Current Assets489.02k181.72k--
Total Current Assets10.69M5.5M3.05M3.15M
Property Plant Equipment1.77M769.46k343.82k246.34k
Intangible Assets512.93k373.37k253.74k289.09k
Other Assets2.86M2.38M1.8M1.26M
Total Assets15.82M9.02M5.45M4.95M
Accounts Payable1.67M242.78k383.18k197.46k
Other Current Liab7.56M1.04M158.89k1.41M
Other Liab55.27k29.09k4.39k2.68k
Deferred Long Term Liab2.75M2.26M1.69M1.1M
Total Current Liabilities26.96M2.94M1.67M1.69M
Total Liab27.63M4.47M1.67M1.7M
Common Stock18.93M17.71M11.47M7.68M
Retained Earnings-38.59M-16.61M-10.12M-6.18M
Treasury Stock7.85M3.46M2.42M1.75M
Other Stockholder Equity7.85M3.46M2.42M1.75M
Total Stockholder Equity-11.81M4.56M3.78M3.25M
Net Tangible Assets-12.32M4.18M3.52M2.96M
Long Term Debt-1.5M--

Cash Flow Statement

Cash Flow Statement history of 4DMedical Limited (ASX:4DX)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Net Income-21.98M-6.49M-3.94M-3.97M
Depreciation584.65k103.94k164.23k126.49k
Change To Netincome10.76M368.03k25.17k799.06k
Change To Account Receivables-87.36k-465.68k108k-281.51k
Change To Liabilities1.44M535.44k-930.71k1.42M
Change To Inventory612.71k-605.96k677.89k-700.69k
Change To Operating Activities1.02M776.32k513.68k451.2k
Total Cash From Operating Activities-7.65M-5.78M-3.38M-2.16M
Capital Expenditures-325.3k-524.57k-157.57k-203.28k
Other Cashflows From Investing Activities372k253.41k523.04k184.91k
Total Cashflows From Investing Activities-786.45k-1.03M-905.71k-944.14k
Net Borrowings14.06M2M1M1M
Other Cashflows From Financing Activities-1.5M-1.5M-1.5M-1.5M
Total Cash From Financing Activities13.78M8.23M4.79M4.04M
Change In Cash5.34M1.42M509.08k934.66k
Issuance Of Stock1.22M6.23M3.79M4.04M
Dividends Paid----